Pancreatic β cell regeneration induced by clinical and preclinical agents
4.5 (69) · $ 6.99 · In stock
Pancreatic β cell regeneration induced by clinical and preclinical agents
Recent progress in pancreatic islet cell therapy, Inflammation and Regeneration
Cells, Free Full-Text
Heterogeneity of HNF1b and SOX9 Proteins in Adult Human and Mouse
Pancreatic β cell regeneration induced by clinical and preclinical agents
Study shows reactivation of beta-like cells in the pancreas to produce insulin
Stem cells therapy for diabetes: from past to future - Cytotherapy
Neratinib protects pancreatic beta cells in diabetes
Construction of tumor organoids and their application to cancer research and therapy
Regeneration of β cells from cell phenotype conversion among the pancreatic endocrine cells
Paris polyphylla Sm. extract enriched with diosgenin as an antidiabetic agent: In vitro and in vivo study - ScienceDirect
PDF) Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats
Regeneration of β cells from cell phenotype conversion among the pancreatic endocrine cells
JCI - Putting pancreatic cell plasticity to the test
Paris polyphylla Sm. extract enriched with diosgenin as an antidiabetic agent: In vitro and in vivo study - ScienceDirect
PDF) A novel dipeptidyl peptidase IV inhibitor DA-1229 ameliorates streptozotocin-induced diabetes by increasing β-cell replication and neogenesis